Member Info for Chelsea11

Great reminder Chester - thanks.

https://citymonitor.ai/transport/why-do-three-buses-always-come-along-once-game-explains-1141

Quiet here currently but would expect a Trading Update and/or M&A news, wouldn’t be too far away now. Inside the next 8 weeks is a reasonable expectation I believe and so if I’m correct, not long to wait.

……..deserved to multi-bag, this is it.

Prosperous for shareholders of course but the implications of what lies behind a sustained hike in the SP to those who are very unwell and to also protect populations from infectious disease are off the scale.

Very best of luck to all Shareholders and anyone in scope of treatments researched, developed and ultimately, commercialised by Scancell.

We’ll be needing a new extension on the lab soon ;-)

Thanks WTP.

Maybe some extra proof that Scancell do actually have a laboratory :-)

Amazing what you can do with a bit of cardboard.

https://www.bbc.co.uk/news/uk-england-humber-62809918

Seem to recall he trashed at least one respected poster here also.

Peaky, did you post on the wrong board?

Cleaner - would be a breach of AIM Rule 11 imo, to hold back price sensitive information just for that reason.

Yes C7!

Of course it could be linked to the number of Likes on the Covidity Ad.

;-)

Later this month, would see the 6 month anniversary of the last COVIDITY RNS.

6 months - you would reasonably think that’s a long time to make a heck of a lot of progress, given the uplift of the Scancell Team resources in general.

“High Noon” type update, cannot be too far away imo.

Frustrating few weeks for everyone here given SP performance but so much to look forward to in the closing months of 2022.

Matt. Bit harsh against a poster who contributes a lot of understanding and insight to this board imo.

Maybe as simple as he’s completed what he was brought in to do?

Here’s what Cliff said in Nov. 2020:

“We are delighted to welcome both Gillies and Robert into their roles at Scancell. Their extensive experience in clinical development within the sector will be invaluable as we progress our pipeline of products through the clinic and towards commercialisation. Following our recent successful fundraises, our initial focus is to progress the clinical development of Modi-1 and SCIB1, in addition to starting our COVIDITY clinical trial in 2021. We are excited by the advice and guidance that Gillies and Robert will be able to provide in advancing these trials and look forward to working with them.”

You could argue perhaps that the above is all done, depending on your view of where we are in the lifecycle of clinical development.

Just a view. Let’s hope September isn’t a dud and we “light up the sky with Scancell fireworks”.

Hasiba will be back with his rocket next.

Oh to meet a nurse at a garden party :-)

That’s Clacton btw :-)

The Wall St link is an irrelevance and not worthy of discussion. You’d be equally as well off popping to Clayton Pier and putting 50p in the Zoltar machine, or asking Bob down the chip shop what he thinks.

“Our expectations for the full year 2022 are unchanged”

Given the current macroeconomic outlook, I’d consider that a very positive statement!

Hopefully the SP will hold up. Let’s see what Mr Market thinks…….

The most plausible explanation for me re the obvious increase in Likes, is that a link to the ad has been published elsewhere ie. not just seen if you happened to look at the Lung Institute Site only. A guess however.